infectious disease

News

After FDA rejection, Gilead nears full EU nod for hep D drug

Gilead Sciences is on the brink of getting full approval for the first drug for hepatitis D virus (HDV) in the EU, after getting a positive opinion from the EMA’s human me

News

BlueDot adds flu to its biothreat warning system

BlueDot hit the headlines in the early stages of the pandemic for using its artificial intelligence platform to predict the outbreak and send out an alert before national

News

Vedanta scores $106.5m to take microbiome drug into ph3

In the face of a challenging biotech financing environment, Vedanta Bio has ra

News

Rezzayo antifungal okayed as Candida auris rings alarm bells

Drug is first new echinocandin to be approved for marketing in the US in more than a decade.

R&D

Was the response to monkeypox a success?

The viral disease that infected a number of people across various countries caused significant alarm for its potential to spread rapidly.

News

FDA advisors back Cidara antifungal rezafungin

An FDA advisory committee has recommended approval of Cidara Therapeutics' once-weekly antifungal therapy rezafungin, setting it up to become the first new option for severe infections caus

After FDA rejection, Gilead nears full EU nod for hep D drug

BlueDot adds flu to its biothreat warning system

Vedanta scores $106.5m to take microbiome drug into ph3

Rezzayo antifungal okayed as Candida auris rings alarm bells

Was the response to monkeypox a success?

FDA advisors back Cidara antifungal rezafungin

Agios shares slide as it abandons sickle cell candidate

Discover a new era of healthcare panel engagement: Grounded ...

infectious disease

Editor's Picks